United States First Circuit

ResetAA Font size: Print

Hochendoner v. Genzyme Corp., 15-1446

In consolidated actions arising out of the shortage of a medication that treats Fabry Disease, a rare genetic disorder that leaves afflicted persons unable to synthesize a key enzyme that helps the body break down fats, the District Court's order of dismissal is affirmed for lack of Article III standing where no specific information is provided regarding the harm, if any, that has befallen each individual plaintiff.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2016/05/23




  • United States First Circuit


FindLaw Career Center

      Post a Job  |  View More Jobs

    View More